Apolipoprotein A1 -75 G/A and +83 C/T polymorphisms: Susceptibility and prognostic implications in breast cancer

Molecular Biology Reports

Volumn 38, Issue 3, 2011, Pages 1637-1643

  Hamrita, Bechr ^a   Nasr, Hela Ben ^a   Gabbouj, Sallouha ^a   Bouaouina, Noureddine ^a,b   Chouchane, Lotfi ^a,c   Chahed, Karim ^a,d  

^a UNIVERSITY OF MONASTIR   (Tunisia)

^b FARHAT HACHED HOSPITAL   (Tunisia)

^c WEILL CORNELL MEDICAL COLLEGE   (Qatar)

^d UNIVERSITY OF SFAX   (Tunisia)

Author keywords

Apolipoprotein A1; Breast carcinoma; Polymorphism; Prognosis; Susceptibility

Indexed keywords

APOLIPOPROTEIN A1; ESTROGEN RECEPTOR; GENOMIC DNA;

ADULT; ALLELE; ARTICLE; BREAST CARCINOMA; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; FEMALE; GENETIC VARIABILITY; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PREMENOPAUSE; PROGNOSIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; TUNISIA;

AGED; APOLIPOPROTEIN A-I; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MENOPAUSE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; RECEPTORS, ESTROGEN;

EID: 79951576443     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-010-0274-0     Document Type: Article

References (24)

1. A Jahangiri 2010 High-density lipoprotein and the acute phase response Curr Opin Endocrinol Diabetes Obes 17 156 160 1:CAS:528:DC%2BC3cXisFeiu78%3D 10.1097/MED.0b013e328337278b 20177380
2. MK Jones A Catte L Li JP Segrest 2009 Dynamics of activation of lecithin:cholesterol acyltransferase by apolipoprotein A-I Biochemistry 48 11196 11210 1:CAS:528:DC%2BD1MXhtlOiur3I 10.1021/bi901242k 19860440
3. LE Moore ET Fung M McGuire CC Rabkin A Molinaro Z Wang, et al. 2006 Evaluation of apolipoprotein A1 and posttranslationally modified forms of transthyretin as biomarkers for ovarian cancer detection in an independent study population Cancer Epidemiol Biomark Prev 15 1641 1646 1:CAS:528: DC%2BD28Xps1ynt74%3D 10.1158/1055-9965.EPI-05-0980 (Pubitemid 44497099)
4. M Tachibana Y Ohkura Y Kobayashi H Sakamoto Y Tanaka J Watanabe, et al. 2003 Expression of apolipoprotein A1 in colonic adenocarcinoma Anticancer Res 23 4161 4167 1:CAS:528:DC%2BD2cXkvV2n 14666619 (Pubitemid 37474914)
5. N Marchi P Mazzone V Fazio T Mekhail T Masaryk D Janigro 2008 Proapolipoprotein A1: a serum marker of brain metastases in lung cancer patients Cancer 112 1313 1324 1:CAS:528:DC%2BD1cXksFKisr4%3D 10.1002/cncr.23314 18257091 (Pubitemid 351429747)
6. V Nosov F Su M Amneus M Birrer T Robins J Kotlerman, et al. 2009 Validation of serum biomarkers for detection of early-stage ovarian cancer Am J Obstet Gynecol 200 639.e1 639.e5 1:CAS:528:DC%2BD1MXmsFylur0%3D 10.1016/j.ajog.2008.12.042
7. YQ Ma GN Thomas B Tomlinson 2005 Association of two apolipoprotein A-I gene MspI polymorphisms with lipid and blood pressure levels Int J Cardiol 102 309 314 10.1016/j.ijcard.2004.10.017 15982502 (Pubitemid 40854048)
8. MI Kamboh CE Aston CM Nestlerode AE McAllister RF Hamman 1996 Haplotype analysis of two APOA1/MspI polymorphisms in relation to plasma levels of apoA-I and HDL-cholesterol Atherosclerosis 127 255 262 1:CAS:528:DyaK28Xnt1Kls70%3D 10.1016/S0021-9150(96)05966-7 9125316 (Pubitemid 27045839)
9. O Olerup H Zetterquist 1992 HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation Tissue Antigens 39 225 235 1:CAS:528:DyaK3sXhsVSktbo%3D 10.1111/j.1399-0039.1992.tb01940.x 1357775
10. N Hyka JM Dayer C Modoux T Kohno CK Edwards III P Roux-Lombard, et al. 2001 Apolipoprotein A-I inhibits the production of interleukin-1beta and tumor necrosis factor-alpha by blocking contact-mediated activation of monocytes by T lymphocytes Blood 97 2381 2389 1:CAS:528:DC%2BD3MXivFOgtb4%3D 10.1182/blood.V97.8.2381 11290601 (Pubitemid 32291485)
11. Z Zhang RC Bast Jr Y Yu J Li LJ Sokoll AJ Rai, et al. 2004 Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer Cancer Res 64 5882 5890 1:CAS:528:DC%2BD2cXmslaks7Y%3D 10.1158/0008-5472.CAN-04-0746 15313933 (Pubitemid 39095590)
12. M Takano Y Kikuchi T Asakawa T Goto T Kita K Kudoh, et al. 2010 Identification of potential serum markers for endometrial cancer using protein expression profiling J Cancer Res Clin Oncol 136 475 481 1:CAS:528: DC%2BC3cXpsFejsg%3D%3D 10.1007/s00432-009-0680-7 19756734
13. JD Smith EA Brinton JL Breslow 1992 Polymorphism in the human apolipoprotein A-I gene promoter region. Association of the minor allele with decreased production rate in vivo and promoter activity in vitro J Clin Investig 89 1796 1800 1:CAS:528:DyaK38XksVWruro%3D 10.1172/JCI115783 1601989
14. R Tuteja N Tuteja C Melo G Casari FE Baralle 1992 Transcription efficiency of human apolipoprotein A-I promoter varies with naturally occurring A to G transition FEBS Lett 304 98 101 1:CAS:528:DyaK38Xlt1Grsbs%3D 10.1016/0014-5793(92)80597-A 1618307
15. DH Jeong HK Kim AE Prince DS Lee YN Kim J Han, et al. 2008 Plasma proteomic analysis of patients with squamous cell carcinoma of the uterine cervix J Gynecol Oncol 19 173 180 1:CAS:528:DC%2BD1MXltFGgsA%3D%3D 10.3802/jgo.2008.19.3.173 19471570
16. S Muntoni L Atzori R Mereu G Satta MD Macis M Congia, et al. 2009 Serum lipoproteins and cancer Nutr Metab Cardiovasc Dis 19 218 225 1:CAS:528:DC%2BD1MXlsVaju7s%3D 10.1016/j.numecd.2008.06.002 18718745
17. E Scotet LO Martinez E Grant R Barbaras P Jenö M Guiraud, et al. 2005 Tumor recognition following Vgamma9Vdelta2 T cell receptor interactions with a surface F1-ATPase-related structure and apolipoprotein A-I Immunity 22 71 80 1:CAS:528:DC%2BD2MXht1Cgsb4%3D 10.1016/j.immuni.2004.11.012 15664160 (Pubitemid 40143452)
18. A Beers MJ Haas NC Wong AD Mooradian 2006 Inhibition of apolipoprotein AI gene expression by tumor necrosis factor alpha: roles for MEK/ERK and JNK signaling Biochemistry 45 2408 2413 1:CAS:528:DC%2BD28XoslOiuw%3D%3D 10.1021/bi0518040 16475830 (Pubitemid 43271341)
19. A Khedhaier S Remadi M Corbex SB Ahmed N Bouaouina S Mestiri, et al. 2003 Glutathione S-transferases (GSTT1 and GSTM1) gene deletions in Tunisians: susceptibility and prognostic implications in breast carcinoma Br J Cancer 89 1502 1507 1:CAS:528:DC%2BD3sXotFeksLc%3D 10.1038/sj.bjc.6601292 14562023 (Pubitemid 37386606)
20. VM Perel'muter MV Zav'ialova SV Vtorushin EM Slonimskaia NG Kritskaia Garbukov EIu, et al. 2008 Genetic and clinical and pathological characteristics of breast cancer in premenopausal and postmenopausal women Adv Gerontol 21 643 653 19432218
21. KE Talbott MD Gammon MG Kibriya Y Chen SL Teitelbaum CM Long, et al. 2008 A CYP19 (aromatase) polymorphism is associated with increased premenopausal breast cancer risk Breast Cancer Res Treat 111 481 487 1:CAS:528: DC%2BD1cXhtV2js7bL 10.1007/s10549-007-9794-2 17975727
22. SJ Santner RJ Pauley L Tait J Kaseta RJ Santen 1997 Aromatase activity and expression in breast cancer and benign breast tissue stromal cells J Clin Endocrinol Metab 82 200 208 1:CAS:528:DyaK2sXkt1egsA%3D%3D 10.1210/jc.82.1.200 8989259 (Pubitemid 27021297)
23. BE Henderson R Ross L Bernstein 1988 Estrogens as a cause of human cancer: the Richard and Hinda Rosenthal Foundation award lecture Cancer Res 48 246 253 1:STN:280:DyaL1c%2FotVShtA%3D%3D 2825969 (Pubitemid 18045752)
24. DC Harnish MJ Evans MS Scicchitano RA Bhat SK Karathanasis 1998 Estrogen regulation of the apolipoprotein AI gene promoter through transcription cofactor sharing J Biol Chem 273 9270 9278 1:CAS:528:DyaK1cXis1eqsrg%3D 10.1074/jbc.273.15.9270 9535920 (Pubitemid 28176220)